Cargando…

Importance of baseline PET/CT imaging on radiation field design and relapse rates in patients with Hodgkin lymphoma

PURPOSE: This study analyzed the impact of pretreatment positron emission tomography/computed tomography (PET/CT) scans on involved site radiation therapy (ISRT) field design and pattern of relapse among patients with Hodgkin lymphoma (HL). METHODS AND MATERIALS: Thirty-seven patients with stage I o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Figura, Nick, Flampouri, Stella, Mendenhall, Nancy P., Morris, Christopher G., McCook, Barry, Ozdemir, Savas, Slayton, William, Sandler, Eric, Hoppe, Bradford S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Scientific Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514251/ https://www.ncbi.nlm.nih.gov/pubmed/28740932 http://dx.doi.org/10.1016/j.adro.2017.01.006

Ejemplares similares

Irradiating Residual Disease to 30 Gy with Proton Therapy in Pediatric Mediastinal Hodgkin Lymphoma
por: Hoppe, Bradford S., et al.
Publicado: (2020)

Proton therapy in the management of non-Hodgkin lymphoma
por: Sachsman, Suzanne, et al.
Publicado: (2015)

Intrafractional Displacement of Cardiac Substructures Among Patients With Mediastinal Lymphoma or Lung Cancer
por: Guzhva, Lidia, et al.
Publicado: (2019)

Whole-Body versus Routine Skull Base to Mid-thigh (18)F-Fluorodeoxyglucose Positron Emission Tomography/ Computed Tomography in Patients with Malignant Melanoma
por: Ozdemir, Savas, et al.
Publicado: (2020)

New agents in relapsed/refractory Hodgkin's lymphoma()
por: Biasoli, Irene, et al.
Publicado: (2017)

Pulmonary Function after Proton Therapy for Hodgkin Lymphoma
por: O'steen, Lillie, et al.
Publicado: (2019)

Consolidative proton therapy after chemotherapy for patients with Hodgkin lymphoma
por: Hoppe, B. S., et al.
Publicado: (2017)

Does the Incidence of Treatment-Related Toxicity Plateau After Radiation Therapy: The Long-Term Impact of Integral Dose in Hodgkin's Lymphoma Survivors
por: Holtzman, Adam L., et al.
Publicado: (2019)

P108: Integrating baseline circulating tumor DNA with interim PET improves outcome prediction in relapsed/refractory classical Hodgkin lymphoma
por: Calabretta, Eleonora, et al.
Publicado: (2022)

Comparative Effectiveness of Proton Therapy versus Photon Radiotherapy in Adolescents and Young Adults for Classical Hodgkin Lymphoma
por: Bates, James E., et al.
Publicado: (2021)

Pericardial Effusion during Proton Therapy in a Patient with Chemorefractory Hodgkin Lymphoma
por: Way, Ashley, et al.
Publicado: (2021)

Unexpected Bone Metastases from Thyroid Cancer
por: Gibiezaite, Sandra, et al.
Publicado: (2015)

Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration
por: Baron, Jonathan A., et al.
Publicado: (2022)

End-of-treatment PET in early-stage Hodgkin lymphoma: valuable in addition to interim PET
por: Chohan, Karan L., et al.
Publicado: (2022)

Granulomatous Lymphangitis Masquerading as Relapsed Hodgkin Disease on FDG PET/CT
por: Mustafa, Mansour, et al.
Publicado: (2018)

Automated quantification of baseline imaging PET metrics on FDG PET/CT images of pediatric Hodgkin lymphoma patients
por: Weisman, Amy J., et al.
Publicado: (2020)

What men want: Results from a national survey on decision making for prostate cancer treatment and research participation
por: Mendenhall, Nancy P., et al.
Publicado: (2021)

Hematopoietic stem cell transplantation for Hodgkin's disease
por: Patah, Poliana, et al.
Publicado: (2011)

Relapsed/Refractory Hodgkin Lymphoma
por: Sheikh, Semira, et al.
Publicado: (2018)

Radiation Therapy in the German Hodgkin Study Group HD 16 and HD 17 Trials: Quality Assurance and Dosimetric Analysis for Hodgkin Lymphoma in the Modern Era
por: Oertel, Michael, et al.
Publicado: (2022)

Analysis of the European baseline survey of norovirus in oysters
Publicado: (2019)

Hodgkin's lymphoma in developing countries: can we go further?()
por: Gaiolla, Rafael Dezen
Publicado: (2017)

AAPM Task Group Report 290: Respiratory motion management for particle therapy
por: Li, Heng, et al.
Publicado: (2022)

Do MRI features at baseline predict radiographic joint space narrowing in the medial compartment of the osteoarthritic knee 2 years later?
por: Madan-Sharma, Ruby, et al.
Publicado: (2008)

Brentuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey
por: Salihoglu, A., et al.
Publicado: (2014)

Changing patterns of relapse in Hodgkin's disease.
por: Duchesne, G., et al.
Publicado: (1989)

Prognostic value of combined MTV and ADC derived from baseline FDG PET/MRI in aggressive non-Hodgkins lymphoma
por: Husby, Trine, et al.
Publicado: (2022)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Does Race Influence Health-related Quality of Life and Toxicity Following Proton Therapy for Prostate Cancer?
por: Bryant, Curtis, et al.
Publicado: (2016)

Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015)

Safety assessment of the process ‘RecyPET Hungária’, based on RecyPET Hungária technology, used to recycle post‐consumer PET into food contact materials
por: Silano, Vittorio, et al.
Publicado: (2018)

NGS - a long-baseline neutrino beam from CERN TO Gran Sasso
Publicado: (1999)

Tibialis Anterior Tendon Transfer for Relapsing Idiopathic Clubfoot
por: Holt, Joshua B., et al.
Publicado: (2015)

Outcome of children with resistant and relapsed Hodgkin's disease.
por: James, N. D., et al.
Publicado: (1992)

Mediastinal Choriocarcinoma Masquerading as Relapsed Hodgkin Lymphoma
por: Lam, Selay, et al.
Publicado: (2011)

Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015)

Non-Hodgkin lymphoma with relapses in the lacrimal glands
por: Couceiro, Rita, et al.
Publicado: (2015)

Relapse of Hodgkin's disease revealed by skin involvement
por: Abakarim, Ouadii, et al.
Publicado: (2022)

Erectile Function, Incontinence, and Other Quality of Life Outcomes Following Proton Therapy for Prostate Cancer in Men 60 Years Old and Younger
por: Hoppe, Bradford S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_u3oe6j86qs9r4kcsfhl9cmq6n7